RAGONESE, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 2.579
AS - Asia 888
EU - Europa 753
Continente sconosciuto - Info sul continente non disponibili 257
SA - Sud America 122
AF - Africa 23
Totale 4.622
Nazione #
US - Stati Uniti d'America 2.381
IT - Italia 692
BD - Bangladesh 295
CN - Cina 214
SG - Singapore 145
HK - Hong Kong 93
CA - Canada 92
BR - Brasile 86
VN - Vietnam 35
IN - India 28
MX - Messico 27
CR - Costa Rica 17
GB - Regno Unito 13
AR - Argentina 12
ID - Indonesia 10
TT - Trinidad e Tobago 9
IQ - Iraq 8
GT - Guatemala 7
JM - Giamaica 7
SA - Arabia Saudita 7
SV - El Salvador 7
CL - Cile 6
FR - Francia 6
MY - Malesia 6
NI - Nicaragua 6
PH - Filippine 6
PK - Pakistan 6
RU - Federazione Russa 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
HN - Honduras 5
LT - Lituania 5
EC - Ecuador 4
EG - Egitto 4
ES - Italia 4
KW - Kuwait 4
PL - Polonia 4
PR - Porto Rico 4
TR - Turchia 4
VE - Venezuela 4
BG - Bulgaria 3
BS - Bahamas 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
NL - Olanda 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
UA - Ucraina 3
BO - Bolivia 2
CO - Colombia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DE - Germania 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
IE - Irlanda 2
JP - Giappone 2
MA - Marocco 2
OM - Oman 2
AG - Antigua e Barbuda 1
AL - Albania 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
FI - Finlandia 1
GD - Grenada 1
GH - Ghana 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KY - Cayman, isole 1
NO - Norvegia 1
PA - Panama 1
QA - Qatar 1
SC - Seychelles 1
UZ - Uzbekistan 1
VI - Stati Uniti Isole Vergini 1
ZA - Sudafrica 1
Totale 4.367
Città #
San Jose 895
Ashburn 480
Council Bluffs 252
Santa Clara 98
Singapore 96
Hong Kong 90
Rome 82
Milan 77
Beijing 68
New York 58
Naples 49
Los Angeles 30
Turin 22
Buffalo 21
Dallas 20
Mexico City 20
Florence 19
Phoenix 18
Bologna 16
Figino 16
Palermo 14
Bari 13
Toronto 13
Catania 12
Brescia 10
San José 10
Hanoi 9
Montreal 9
Charlotte 8
Ho Chi Minh City 8
Belo Horizonte 7
Cagliari 7
Chicago 7
Philadelphia 7
Vancouver 7
Verona 7
Chaguanas 6
Columbus 6
Genoa 6
Houston 6
Managua 6
Modena 6
Monza 6
San Salvador 6
Kingston 5
Miami 5
Mumbai 5
North Bergen 5
Padua 5
Pescara 5
Seattle 5
Atlanta 4
Da Nang 4
Guatemala City 4
Jakarta 4
Kuala Lumpur 4
Kuwait City 4
London 4
Reggio Emilia 4
São Paulo 4
Baghdad 3
Bangkok 3
Bolzano 3
Brooklyn 3
Cairo 3
Calgary 3
Chennai 3
Dakar 3
Heredia 3
Las Vegas 3
Nairobi 3
Nassau 3
Ottawa 3
Parma 3
Porto Alegre 3
Ravenna 3
Regina 3
Riyadh 3
Sofia 3
St Louis 3
Tampa 3
Taranto 3
Windsor 3
Afragola 2
Ahmedabad 2
Albany 2
Algiers 2
Anaheim 2
Ascea 2
Barinas 2
Busto Arsizio 2
Candelù 2
Casalnuovo di Napoli 2
Castellammare di Stabia 2
Caxias do Sul 2
Cercola 2
Cesara 2
Chieti 2
Cincinnati 2
Cleveland 2
Totale 2.797
Nome #
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 128
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 82
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients 66
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 51
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 51
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 44
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 44
Organisational impact and patient management models for biomarker integration in multiple sclerosis care in Italy: the 0Tolerance project 43
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 40
Signs and symptoms of COVID-19 in patients with multiple sclerosis 40
The role of dopaminergic signalling from physiology to neuroprotection in acute and chronic disorders 39
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 39
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 39
Cholesterol abnormalities in a cohort of Sicilian patients with multiple sclerosis 38
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 35
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 34
Taopatch® combined with home-based training protocol to prevent sedentary lifestyle and biochemical changes in MS patients during COVID-19 pandemic 34
A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological research 34
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis 34
Stroke incidence and case fatality: a 9-year prospective population-based study in an elderly population of Bagheria, Italy 34
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 33
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 31
A new road to improve vitamin D and balance through Taopatch® and proprioceptive protocol in Multiple Sclerosis patients 30
Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy 30
The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseases 30
High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy 30
Transcranial magnetic resonance-guided focused ultrasound thalamotomy as a safe treatment option in multiple sclerosis patients with essential tremor 29
Frequency and determinants for hemorrhagic transformation of cerebral infarction 29
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 28
Risk of Cognitive Decline in Women with Parkinson’s Disease Is Reduced by Early Age at Menarche 28
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients 28
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 27
Multiple sclerosis survival: a population-based study in Sicily 27
Optimizing the "Time to pregnancy" in women with multiple sclerosis: the OPTIMUS Delphi survey 27
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis 26
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 26
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 26
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study 26
A new role of CYP2R1 in Multiple Sclerosis 25
Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke : Posterior ischemic stroke and hemorrhagic transformation 25
The efficacy of anaerobic training on multiple sclerosis symptoms management 25
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex 25
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 25
An unexpected association between intracranial hypotension and split cord malformation 24
Incidence of amyotrophic lateral sclerosis in Sicily: A population based study 24
Sex differences in multiple sclerosis treatment with disease modifying drugs: a step towards gender neurology 24
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 24
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 24
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 24
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 23
CYP27A1, CYP24A1, and RXR-α Polymorphisms, Vitamin D, and Multiple Sclerosis: a Pilot Study 23
Correction: Shekarkar Azgomi et al. A Rapid and Simple Multiparameter Assay to Quantify Spike-Specific CD4 and CD8 T Cells after SARS-CoV-2 Vaccination: A Preliminary Report 23
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis 23
Do exergames combined with physical exercise improve upper limb motor function in people with multiple sclerosis? Randomized clinical trial 23
Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status 23
Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis 23
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 22
Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura 22
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 22
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre 22
Association of CYP2R1 rs10766197 with MS risk and disease progression 22
Efficacy and Safety of Rescue Treatment with Plasma Exchange in Patients with Acute Inflammatory Neurological Disorders: A Single Center Experience 22
Frequency and determinants for hemorrhagic transformation of cerebral infarction 22
Epidemiology of Epilepsy 22
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 22
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 21
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study 21
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 21
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study 21
A population-based survey of cognitive performance in a Sicilian elderly community 21
Disability assessment using Google Maps 20
Leprosy: report of a case with severe peripheral neuropathy 20
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 20
Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors 20
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 20
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire 20
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 20
Long-term survival of Parkinson’s disease: a population-based case-control study 20
Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects 20
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients 20
Progressive multifocaL LEUCOENCEPHALOPATHY DURING TACROLIMUS THERAPY FRO LIVER TRANSPLANTATION 20
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 19
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 19
Cigarette Smoking, coffee consumption and multiple sclerosis: a case-control study 19
Informing MS patients on treatment options: a consensus on the process of consent taking 19
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 19
TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP 19
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 19
Tocilizumab treatment in MOGAD: a case report and literature review 18
Idiopathic Parkinson's disease and diabetes: results from a case-control study 18
Dropped head as an unusual presenting sign of myasthenia gravis 18
The Impact of In-Hospital Disease Modifying Treatments on Mental and Physical Burden in Caregiver of Patients With MS 18
Clinical and genetic analysis of a large Sicilian family with Essential Tremor 17
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 17
A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease 17
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study 17
Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection 17
A post-marketing comparison study on disability modification in progressive multiple sclerosis after interferon beta-1b or mitoxantrone therapy 17
Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings 17
Diabetes preceding Parkinson's disease onset. A case-control study 17
Totale 2.754
Categoria #
all - tutte 22.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202555 0 0 0 0 0 0 8 11 5 2 14 15
2025/20262.719 10 1 5 11 25 278 170 256 1.039 209 456 259
2026/20271.848 243 92 645 868 0 0 0 0 0 0 0 0
Totale 4.622